Drug profile · INN
sumatriptan succinate
SUMATRIPTAN SUCCINATE
sumatriptan succinate (SUMATRIPTAN SUCCINATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Tonix Pharmaceuticals Holding. Route of administration: iontophoresis. Current US regulatory status: approved.
Drug details — sumatriptan succinate
- US status
- approved
- Class
- —
- Route
- IONTOPHORESIS
- Patents
- 20
- Programs
- 4
- Data quality
- 0.89
Quick answer
sumatriptan succinate (SUMATRIPTAN SUCCINATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Tonix Pharmaceuticals Holding. Route of administration: iontophoresis. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 1d (5-HT1d) receptor agonist
Primary target: 5-hydroxytryptamine receptor 1B
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12383733
Iontophoresis-based patch type medicine absorption device
granted -
US 12304901
Selective ligands for tau aggregates
granted -
US 12156864
Analogs of cyclobenzaprine and amitryptilene
granted -
US 12097183
Pharmaceutical composition for treating migraine
granted -
US 11998516
Methods and compositions for treating depression using cyclobenzaprine
granted -
US 11975161
Drug releasing coatings for balloon catheters
granted -
US 11566032
Radio-protective and chemo-protective substituted thiols
granted -
US 11376404
Drug releasing coatings for medical devices
granted -
US 10994055
Drug releasing coatings for medical devices
granted -
US 10946027
Tianeptine oxalate salts and polymorphs
granted -
US 10912932
Drug releasing coatings for balloon catheters
granted -
US 10912931
Drug releasing coatings for balloon catheters
granted -
US 10835719
Drug releasing coatings for medical devices
granted -
US 10485959
Drug releasing coatings for balloon catheters
granted -
US 10485958
Drug releasing coatings for balloon catheters
granted -
US 10449203
Tianeptine oxalate salts and polymorphs
granted -
US 9918948
Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
granted -
US 9764065
Drug releasing coatings for medical devices
granted -
US 9757351
Medical device rapid drug releasing coatings comprising oils, fatty acids and/or lipids
granted -
US 9757544
Drug releasing coatings for medical devices
granted
Frequently asked questions
What is sumatriptan succinate?
sumatriptan succinate (SUMATRIPTAN SUCCINATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Tonix Pharmaceuticals Holding. Route of administration: iontophoresis. Current US regulatory status: approved.
What is the brand name for sumatriptan succinate?
SUMATRIPTAN SUCCINATE is a marketed brand name for sumatriptan succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sumatriptan succinate?
sumatriptan succinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.